HomeInsightsPE

Piramal Pharma Ltd PE Ratio

Piramal Pharma Ltd PE Ratio

stocks purchased

₹ 5.4 Cr

Volume transacted

stocks purchased

213.7 K

stocks traded

Last Updated time: 30 Oct 9.00 AM

Image

Piramal Pharma Ltd

NSE: PPLPHARMA

PE

0

Last updated on: Oct 30, 2024

Key Highlights

  • The P/E Ratio of Piramal Pharma Ltd is 0 as of 30 Oct 9.00 AM.
  • The P/E Ratio of Piramal Pharma Ltd changed from 991.5 on March 2024 to 991.5 on March 2024 . This represents a CAGR of 0.00% over 1 years. .
  • The Latest Trading Price of Piramal Pharma Ltd is ₹ 252.35 as of 30 Oct 15:30.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.2. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 158.1. The PE Ratio of Textiles industry is 37.6. In 2024.

Historical P/E Ratio of Piramal Pharma Ltd

No data available

Company Fundamentals for Piramal Pharma Ltd

No data available

Image

Piramal Pharma Ltd

NSE: PPLPHARMA

PRICE

252.35

1.50 (0.60%)

stock direction

Last updated on: Oct 30 03:30 PM

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Piramal Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
30 Oct 2024252.35
29 Oct 2024250.85
28 Oct 2024246.4
25 Oct 2024244.4
24 Oct 2024256.4
23 Oct 2024216.7
22 Oct 2024215.15
21 Oct 2024228.05
18 Oct 2024225.4
17 Oct 2024224.45

SWOT Analysis Of Piramal Pharma Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Piramal Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Piramal Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Piramal Pharma Ltd033,455
Sun Pharmaceuticals Industries Ltd394,44,465
Divis Laboratories Ltd931,56,264
Cipla Ltd241,14,473
Torrent Pharmaceuticals Ltd611,06,171
Mankind Pharma Ltd531,05,299

Key Valuation Metric of Piramal Pharma Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Piramal Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Piramal Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Piramal Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Piramal Pharma Ltd

No data available

* All values are in crore

Historical Dividend Payout of Piramal Pharma Ltd

No data available

* All values are in %

About Piramal Pharma Ltd

  • Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over 100 countries.
  • It includes an integrated CDMO business, CHG business and ICH business, selling over-the-counter products in India.
  • In addition, it has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. Piramal Pharma Solution provides integrated drug discovery, development, and manufacturing services for both drug substances, i.e. active pharmaceutical ingredients (APIs) and drug products, i.e. formulations across the life cycle of a molecule, from discovery and clinical development to commercial launch.

Piramal Pharma Ltd News Hub

News

Piramal Pharma receives SBTi validation for its GHG commitment

Piramal Pharma has embarked on its sustainability journey as the Science Based Targets ini...

Read more

2024-09-17 00:00:00

News

Piramal Pharma to invest $80M to expand its Lexington, Kentucky facility

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Or...

Read more

2024-09-30 00:00:00

News

Piramal Pharma to declare Quarterly Result

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 23 October ...

Read more

2024-10-15 00:00:00

News

Piramal Pharma consolidated net profit rises 350.00% in the September 2024 quarter

Net profit of Piramal Pharma rose 350.00% to Rs 22.59 crore in the quarter ended September...

Read more

2024-10-24 00:00:00

News

Broader mrkt outperforms; PSU bank shares in demand

The headline equity benchmarks traded with minor gains in morning trade. The Nifty traded ...

Read more

2024-10-24 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Piramal Pharma Ltd

What is the current PE Ratio of Piramal Pharma Ltd?

The Current PE Ratio of Piramal Pharma Ltd is 0.0 as on 30 Oct 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 30 Oct 2024.

What was the PE Ratio of Piramal Pharma Ltd last year?

The PE Ratio of Piramal Pharma Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Piramal Pharma Ltd indicate about its stock?

The PE Ratio of Piramal Pharma Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Piramal Pharma Ltd.

What is the PE Ratio Growth of Piramal Pharma Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Piramal Pharma Ltd grew by -% whereas, the EPS ratio grew by -125.4.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*